Searched for
PHARMACEUTICAL AND WELLNESS COMPANY
IPA seeks to regularise 'legacy' drugsThe Indian Pharmaceutical Alliance seeks to regularize many drugs. These drugs have been marketed for years without central approval. Examp...- ET Health Conclave 2026: Healthcare leaders reimagine the future of medicine through innovation, prevention and technologyThe ET Health Conclave 2026 celebrated healthcare professionals and institutions. Leaders shared insights on healthcare infrastructure and ...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 20%It was after quite some time that market breadth, always a better indicator of underlying sentiment, was positive for a few trading session...
- Private equity firm Creador in talks to buy into generic drug co Leeford HealthPrivate equity firm Creador is in advanced talks to acquire a stake. The firm expects to invest ₹800 crore in Leeford Healthcare. This acqu...
- ITC's Sanjiv Puri says CPP acquisition marks 'defining milestone' for paper businessIn a social media post, Puri welcomed the CPP workforce to ITC, saying the integration brings together two enterprises with a shared commit...
- The ethanol story is changing. Is investing in the ecosystem the better way? 15 stocks across different market cap segmentsThe ethanol story started simply enough: Cut India's dependence on imported crude oil. It would save foreign exchange. Give farmers a new a...
- Employees skipping annual health check-ups face nearly threefold higher hospitalisation risk: CII-MediBuddy reportEmployees skipping annual health checkups face triple the hospitalization risk. This group also accounts for a large share of insurance cla...
- India ready for a premium wealth show while US missiles rattle the worldIndia's festive shopping season is set to highlight the country's premiumisation boom despite global uncertainty triggered by the US-Iran w...
- Sun Pharma Q1 Results: Profit rises 27% YoY to Rs 2,895 crore; revenue climbs 10.5%Sun Pharma Q1 Results: Sun Pharma reported a 27% YoY rise in Q1 net profit to Rs 2,895 crore, while revenue grew 10% to Rs 15,300 crore, dr...
- Why Axis Mutual Fund is asking investors to look at largecaps as wellFollowing the sharp re-rating in small- and midcaps, Axis Mutual Fund has urged investors to revisit largecaps, saying their valuations hav...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe next time uncertainty over the firing of missiles in the Gulf region makes you anxious, remember this: It is not the first time that gl...
- Motilal Oswal raises mid and smallcap allocation to 50%, stays neutral on Indian equitiesMotilal Oswal Private Wealth favors Indian mid and small-cap stocks. They are increasing allocations to these segments by ten percentage po...
- Kazakhstan eyes stronger trade ties with West BengalKazakhstan's ambassador expressed keen interest in expanding business engagement with West Bengal. The nation views West Bengal as a crucia...
- Gujarat industry seeks easier access to incentives, lower cost of doing businessIndustry stakeholders say the opportunity for them lies in strengthening the link between its large industrial base and MSMEs while reducin...
- Can AI shorten India's rare disease diagnosis journey? New tool aims to do just thatSanofi has launched AccelRare, an AI tool aiding doctors in rare disease pre-diagnosis. This platform generates potential diagnoses within ...
- Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...
- Pharma mutual funds top return charts across horizons. Should investors chase the rally or stay cautious?Pharma mutual funds are leading returns in CY2026, driven by strong earnings, defensive demand, and US export growth. Despite recent outper...
- Pharma deal activity hits four-quarter low, but mega Sun Pharma acquisition drives valueIndia's pharma and healthcare sector recorded 65 deals worth $13.9 billion in Q2 CY2026, with volumes falling 17% quarter-on-quarter to a f...
- Akums to acquire Oriflame India's manufacturing businessAkums Drugs and Pharmaceuticals will acquire Oriflame India's manufacturing business. This significant deal is valued at fifty-six crore ru...
- Indian pharma firms may yet survive Trump's 200% tariff bombshellDonald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...
Load More
